Oxygen
Drugoxygen delivery by ETT/ SGA connected to bag/valve/oxygen reservoir
NCT Number: NCT02499042
This Phase 2 study aims to determine the feasibility of paramedic titration of oxygen delivery in adult patients who have been resuscitated from OHCA.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
SA Ambulance Service, Adelaide, South Australia, Australia
This Phase 2 study aims to test whether paramedic titration of oxygen is feasible and results in an equivalent number of patients arriving at the ED with a safe oxygen level compared with the current approach of 100% oxygen.
Hypothesis: There is no difference in the proportion of OHCA patients who arrive at the emergency department with oxygen saturation greater than or equal to 90% whether they received an inspired oxygen fraction of 100% achieved by a flow rate of 10 litres per minute compared to a titrated oxygen fraction achieved by a flow rate of 2 litres per minute.
This is a Phase 2, multi-centre, prospective, randomised study to be conducted in Melbourne and Adelaide.
During cardiac arrest, the patient will receive the current standard of care with oxygen delivery (≥10L/min) by ETT/ SGA connected to bag/valve/ oxygen reservoir.
If ROSC is achieved, all the standard post resuscitation treatments will be given as per current ambulance Clinical Practice Guidelines, except for the amount of oxygen delivered.
The initial ventilation post ROSC for two minutes will be 600mL x 10L/ minute with oxygen flow rate ≥10L/min until a satisfactory pulse oximeter trace and reading is achieved.
After the eligibility criteria are met, the patients will be randomised by the opening of an opaque envelope containing a computer generated allocation to either continued oxygen >10L/min or decreased ("titrated") oxygen 2L/min with a target oxygen saturation of 90-94%.
Patients allocated to oxygen >10L minute ("standard care") will continue on this therapy to hospital.
In the 2L/min oxygen group, the oxygen flow will be changed immediately back to >10L/min if:
For patients with ROSC in whom intubation is planned, ventilation with high-flow oxygen will continue during the intubation process and randomisation will be delayed until 2 minutes after the ETT is confirmed as correctly placed using ETCO2 and the pulse oximeter trace reads ≥95%.
At ED handover, the patient will receive oxygen therapy as determined by the treating emergency medicine physician.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
oxygen delivery by ETT/ SGA connected to bag/valve/oxygen reservoir
Time frame: baseline
Oxygen saturation measured on arrival at hospital by paramedics
Monash University
Other
rEduction of oXygen After Cardiac arresT (EXACT): a Pilot Study
Acronym: EXACT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02007499
Cardiac Arrest, Cardiopulmonary Arrest
Milwaukee, Wisconsin, United States
View Trial DetailsNCT03065647
CPR, Cardiac Arrest
Ann Arbor, Michigan, United States
View Trial DetailsNCT03863015
Cardiovascular Diseases, Heart Arrest
Copenhagen, Denmark
View Trial DetailsNCT01946932
Brain Diseases, Brain Injuries
Copenhagen, Denmark
View Trial Details